3D Systems Announces VSP Bolus to Optimize Radiotherapy Targeting, Improve Patient Experience
ROCK HILL, SC, USA, Apr 22, 2022 – 3D Systems (NYSE:DDD) announced its entry into the radiation oncology market with FDA 510(k) clearance of VSP Bolus, a solution designed to deliver high-quality patient-specific radiotherapy treatment accessories. As the latest addition to the company’s VSP portfolio of personalized medical devices, VSP Bolus is the only solution on the market […]
3D Systems Announces VSP Bolus to Optimize Radiotherapy Targeting, Improve Patient Experience
2022-04-22 22:04